- Gilead Sciences, Inc. (Oceanside, CA)
- …goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T- cell therapies have changed the paradigm. But we're not finished yet. Join ... cancer. Every single day, we seek to establish a line between that purpose and our day-to- day work....plans. Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of… more
- Gilead Sciences, Inc. (Santa Monica, CA)
- …goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T- cell therapies have changed the paradigm. But we're not finished yet. Join ... and secondary insights and analytics deliverables + Guiding the development of insights and analytics projects to inform strategic...is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed… more
- Gilead Sciences, Inc. (Santa Monica, CA)
- …goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T- cell therapies have changed the paradigm. But we're not finished yet. Join ... Responsible for directing and executing scientific research for the development of drug candidates or the research support of...is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed… more
- Bristol Myers Squibb (San Diego, CA)
- …uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work ... the transition of drug candidates from early to late-stage clinical development , their approval and life cycle management. Early-stage translational development… more
- Stanford University (Stanford, CA)
- …faculty member at any rank (assistant to full professor) in the University Tenure Line (UTL), University Medical Line (UML), or Non-Tenure Line -Research ... in candidates who have a strong background in stem cell biology and experience with combining multiple approaches, such...organoid methodologies and _in vivo_ models, to investigate the development of sensory organs of the head and neck… more
- Sumitomo Pharma (Sacramento, CA)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For...SOPs, and fosters a culture of "Safety First" in line with -SMPA's values and related behaviors. **Key Core… more
- Gilead Sciences, Inc. (Santa Monica, CA)
- …goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T- cell therapies have changed the paradigm. But we're not finished yet. Join ... materials, consulting agreements, services agreements, vendor agreements, evaluation agreements, development agreements, licenses, work orders, and master agreements. +… more
- Gilead Sciences, Inc. (Santa Monica, CA)
- …goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T- cell therapies have changed the paradigm. But we're not finished yet. Join ... include: **Sales Planning and Analytics** + Lead field force KPI development , performance reporting including design and implementation of field facing dashboards… more
- Gilead Sciences, Inc. (Santa Monica, CA)
- …goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T- cell therapies have changed the paradigm. But we're not finished yet. Join ... strategic and execution-focused Sr Manager, Data Management to lead the development , stewardship, and operations of scalable, analytics-ready data products. This… more
- Gilead Sciences, Inc. (Foster City, CA)
- …goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T- cell therapies have changed the paradigm. But we're not finished yet. Join ... analyses of field effort and effectiveness. + Drive the development of standard weekly, monthly, and quarterly metrics, reports...is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed… more